Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 25, 2023
[Post-COVID syndrome in the neurological practice]M A Cherdak, E A MkhitaryanZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 2, 2024
[Cognitive impairment in cerebrovascular diseases]A N Bogolepova, E A Mkhitaryan, O S LevinNeuroscience and Behavioral Physiology|July 9, 2008
Effects of cerebrolysin on moderate cognitive impairments in cerebral vascular insufficiency (a clinical-electrophysiological study)I V Damulin, N N Koberskaya, E A MkhitaryanNeuroscience and Behavioral Physiology|December 6, 2005
Comparative analysis of cognitive impairments in lewy body dementia and Alzheimer's diseaseI S Preobrazhenskaya, E A Mkhitaryan, N N YakhnoZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 29, 2024
[Meta-analysis of randomized controlled trials of the effectiveness of Prospekta in the treatment of vascular cognitive impairment of varying severity]V A Parfenov, A N Bogolepova, E A MkhitaryanZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 11, 2024
[Cerebral amyloid angiopathy]E A Mkhitaryan, V V Fateeva, P R KamchatnovZhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 17, 2022
[Vitamin B12 in the treatment and prevention of cognitive disorders in the elderly]M A Cherdak, E A Mkhitaryan, V V Zakharov, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 22, 2022
[Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the international multicenter, randomized, double-blind, placebo-controlled study of sequential therapy in patients with chronic brain ischemia MEMO)]V V Zakharov, O N Tkacheva, E A Mkhitaryan, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 5, 2020
[Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke (results of additional sub-analysis of a randomized double blind multicenter placebo-controlled study, in parallel groups trial EPICA)]L V Stakhovskaya, E A Mkhitaryan, O N Tkacheva, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 29, 2025
[Diagnosis of Alzheimer's disease using biological markers in corticobasal syndrome]D A Grishina, V V Grinyuk, M R Nodel, et al.Pageof 3